Like an air of déjà vu.
Unscrewing financial markets, closing borders, events canceled one after the other, restrictions imposed again, as in Austria or the Netherlands… The disorderly atmosphere furiously recalls the beginning of March 2020. The uncertainty is making a comeback in the face of the combined threat of a fourth or fifth wave (depending on the country) of the coronavirus and a potentially - or not - dangerous mutant variant.
Admittedly, we now have the vaccines but, there again, the doubt sets in.
Read also
Variant Omicron: the great concern of tourism professionals
Two little words from the boss of Moderna, Tuesday, in the
Financial Times
, were enough to ignite the powder.
Stéphane Bancel expects a
"significant drop"
in the efficacy of vaccines against the Omicron variant.
"All I talked to scientists say
:
" It will not be good "
, he insisted.
Pharmaceutical manufacturers estimate that they need a few months to adapt the formulas of their serums.
Meanwhile, the World Organization
This article is for subscribers only.
You have 86% left to discover.
To cultivate one's freedom is to cultivate one's curiosity.
Continue reading your article for € 1 the first month
I ENJOY IT
Already subscribed?
Log in
